MUR
33
-5
DTE
40
4
ADI
72
2
PSA
46
-2
ABBV
46
-4
PCAR
62
-2
CCI
34
-2
NOV
48
-4
SYK
30
2
BIIB
46
-3
JNJ
54
-3
NEE
52
2
EFX
52
2
CMG
61
3
PAYX
32
-4
PSX
35
-4
ORCL
26
2
DUK
57
2
MET
63
-4
WM
57
-2
MUR
33
-5
DTE
40
4
ADI
72
2
PSA
46
-2
ABBV
46
-4
PCAR
62
-2
CCI
34
-2
NOV
48
-4
SYK
30
2
BIIB
46
-3
JNJ
54
-3
NEE
52
2
EFX
52
2
CMG
61
3
PAYX
32
-4
PSX
35
-4
ORCL
26
2
DUK
57
2
MET
63
-4
WM
57
-2
Financhill
Back

T Rowe Price Capital Appreciation Equity ETF Vs. Insmed, Inc. Industry Stock Comparison

Sell
43

TCAF
T Rowe Price Capital Appreciation Equity ETF

Last Price:
$37.86
Seasonality Move:
1.3%
Sell
40

INSM
Insmed, Inc.

Last Price:
$166.55
Seasonality Move:
7.61%
Sell
43
T Rowe Price Capital Appreciation Equity ETF (TCAF) is a Sell

Is T Rowe Price Capital Appreciation Equity ETF a Buy, Sell or Hold?

  • The current T Rowe Price Capital Appreciation Equity ETF [TCAF] share price is $37.86. The Score for TCAF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • TCAF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy, Sell or Hold?

  • The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCAF Stock Price Chart

What is T Rowe Price Capital Appreciation Equity ETF's stock price today?

  • The T Rowe Price Capital Appreciation Equity ETF share price today is $37.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCAF is experiencing slight selling pressure.

INSM Stock Price Chart

What is Insmed, Inc.'s stock price today?

  • The Insmed, Inc. share price today is $166.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

TCAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.33 Buy
Relative Strength Index (14 RSI): 44.46 Sell
Chaikin Money Flow: -404906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.81 - 38.53) Sell
Bollinger Bands (100): (36.85 - 38.47) Buy

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: -270452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.54 - 208.08) Sell
Bollinger Bands (100): (130.7 - 191.18) Buy

TCAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.05 Sell
20-day SMA: 38.19 Sell
50-day SMA: 38.3 Sell
200-day SMA: 35.5 Buy
8-day EMA: 14.9 Buy
20-day EMA: 6.84 Buy
50-day EMA: 2.9 Buy
200-day EMA: 0.75 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.36 Sell
20-day SMA: 199.79 Sell
50-day SMA: 186.64 Sell
200-day SMA: 121.17 Buy
8-day EMA: 191.25 Sell
20-day EMA: 194.86 Sell
50-day EMA: 184.92 Sell
200-day EMA: 135.61 Buy

T Rowe Price Capital Appreciation Equity ETF Earnings Growth & TCAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed, Inc. Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.

T Rowe Price Capital Appreciation Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):